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Abstract: 
Introduction: 
Total hip replacement is a common and effective surgical intervention for patients with 
debilitating joint pain but it does represent a significant surgical intervention. For such 
interventions, blood loss is a potential cause of morbidity and mortality. Optimisation 
of surgical interventions focuses on reducing such risks. The aim of this study was to 
determine whether the order of surgical steps, preparing the femur before or after the 
acetabulum, was associated with the amount of total blood loss in total hip replacement.  
Methods: 
We performed a retrospective study of 100 patients undergoing primary total hip 
replacement between 2014 and 2018. This was a before and after (interrupted time 
series) study around the introduction of femur first preparation for total hip replacement 
in our unit. Fifty patients underwent a standard femoral preparation after placement of 
the acetabular component. The second 50 patients had the femoral canal prepared and 
broached prior to the acetabular component. Estimated blood volume and total blood 
loss associated with the perioperative period were calculated for each patient and a 
multiple regression analysis performed to account for other patient and surgical 
variables associated with perioperative blood loss. 
 
 
Results: 
There was a small reduction in total blood loss for the group who underwent femoral 
preparation prior to acetabular preparation with a mean difference of 39mls. This 
difference however was not clinically or statistically (p=0.392) significant. Gender 
(p<0.0001), Body Mass Index (BMI; p<0.0001), preoperative haematocrit (p<0.0001), 
postoperative haematocrit (p<0.0001) and age (p=0.004) were the only factors 
significantly associated with the total volume of blood loss. 
Conclusions: 
Whether the femur was prepared before or after the acetabulum did not significantly 
predict the total volume of blood loss for primary total hip replacement. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction: 
The complications of total hip replacement (THR) are well documented [1]. THR has 
a reported mean total blood loss of 1,510 mL, with a calculated hidden loss of 471 mL 
[2]. Blood loss and symptoms of anaemia may necessitate the need for blood 
transfusion which carries additional risk and is associated with increased hospital length 
of stay, increased morbidity (including infection), poorer postoperative outcomes and 
increased mortality [3-7].  
Ideally, patients undergoing THR will undergo haematology screening and 
haemoglobin optimisation preoperatively [8]. Surgical teams will employ blood loss 
reduction techniques and post-operative protocols to reduce total blood loss and the 
need for transfusion. Techniques which have led to a decrease in total blood loss include 
the use of cautery, tranexamic acid, maintenance of normal body temperature, improved 
dissection and shorter operating times [5].  
While haemostasis of the soft tissue is achievable intra-operatively, blood loss 
from cut bone surfaces following femoral preparation and acetabular reaming is often 
not achieved until placement of the implant rendering a tamponade effect. The senior 
author (RB) was performing a THR for an osteoarthritic hip in an achrondroplasic 
patient. Concerns about the small femur led to a pre-operative plan to prepare the 
femoral canal first – this proved to be as straightforward as preparing a THR in the 
conventional fashion. Since this date the senior author has always prepared the femur 
first when using a modular femoral broaching system for THR. 
We hypothesised that an appropriately sized femoral broach placed soon after 
the femoral neck is resected will tamponade femoral bleeding expeditiously, leading to 
a reduced bleeding time, which may translate to a reduction in total blood loss. To 
further our understanding of intra-operative blood loss in THR, we compared cases of 
THR where the femoral broach was inserted before and after acetabular preparation. 
 Methods  
One hundred consecutive patients who underwent primary THR at a tertiary elective 
Orthopaedic unit between 2014 and 2018 were included. Of the 100 patients included, 
50 underwent femoral canal preparation and femoral tamponade with the final broach 
before acetabular preparation and 50 underwent acetabular preparation prior to femoral 
canal preparation. Both cohorts of patients were consecutive. 
The primary outcome measure for the two arms of this study was total blood 
loss. The estimated blood volume for each patient was calculated according the method 
of Nadler et al. [9]. Here the blood volume is calculated by the formula: 
 
Estimated blood volume=k1*height(m)+k2*weight(kg)+k3 
For males, k1=0.3669, k2=0.03219 and k3=0.6041. For females, k1=0.3561, 
k2=0.03308 and k3=0.1833. Total blood loss associated with the total hip replacement 
procedure and accounting for hidden blood loss was calculated according to the formula 
of Gross et al. [10] as described by Liu et al. [11] where: 
 
Total blood loss=Estimated blood volume ((Hct preop-Hct postop))/((Hct 
preop+Hct postop)/2) 
 
This is a single centre, two surgeon before and after comparison study, otherwise 
described as an interrupted time series. The inclusion criteria were patients undergoing 
primary total hip joint replacement. The exclusion criteria were patients undergoing 
primary surgery with a non-modular broaching system, revision surgery, complex 
primary arthroplasty requiring bone graft, osteotomy or revision implants. 
 Procedure: All THRs were performed under the care and supervision of the senior 
authors (MRW and RB) through a posterior approach with haemostasis achieved during 
the approach. Tranexamic acid was routinely given at induction (1g IV) with no 
exclusions. The THR prostheses used were all DePuy Synthes (Warsaw, IN, USA: C 
stem AMT or Corail stems and Ogee or Pinnacle acetabular components). The type of 
fixation (cemented, hybrid or uncemented) was at the discretion of the surgeon 
according to patient age, activity and bony anatomy. All wounds were closed in layers 
using the same technique with absorbable sutures. Skin closure was either with a barbed 
continuous suture or an absorbable monofilament suture. 
Femur First: In the ‘femur first’ group, after the surgical approach, dislocation of the 
hip and femoral neck resection, the surgeon went on to prepare the canal with the use 
of sequential broaches. Once the appropriately sized broach was placed into the femur, 
it was left in situ and the femur retracted anteriorly to expose the acetabulum for 
preparation and insertion of definitive acetabular components. The THR was then 
trialled with modular neck and head on the femoral broach. Once trialling was complete 
the femoral side of the THR was completed. (This technique can be viewed at 
www.OrthOracle.com published 2/8/18) 
Femur Second: In the ‘femur second’ group, following the femoral neck resection, the 
femur with raw bone surface was retraced anteriorly for exposure of the acetabulum. 
The acetabulum was prepared and the definitive cup placed. The femur was then 
prepared with the use of broaches in a standard fashion, trialled and then the definitive 
prosthesis implanted. 
Further variables which could affect blood loss were collected; gender, Body Mass 
Index (BMI), age at intervention, American Society of Anaesthesiologists (ASA) grade, 
THR fixation (cemented, hybrid, uncemented), use of anticoagulants preoperatively 
(aspirin, clopidogrel, novel anticoagulants or warfarin), preoperative haematocrit, 
postoperative haematocrit, and postoperative thromboprophylaxis (clexane, aspirin, 
clopidogrel, novel anticoagulants or warfarin) 
 
Statistical Methods 
Statistical calculations were performed using GraphPad InStat and Prism (GraphPad 
Software Inc, La Jolla, CA, USA). Data distribution was assessed with the 
Kolmogorov-Smirnov test, where data was normally distributed, it was described with 
the mean and standard deviation (SD), where it was not normally distributed, it was 
described with the median and interquartile range (IQR). Multiple regression analysis 
was performed on cases with complete data. The dependent variable was the total 
volume of blood loss (including hidden blood loss), the independent variables were 
whether the femur was prepared first (before the acetabulum), gender, Body Mass Index 
(BMI), age at intervention, American Society of Anaesthesiologists (ASA) grade, THR 
fixation (cemented, hybrid, uncemented), use of anticoagulants preoperatively (aspirin, 
clopidogrel, novel anticoagulants, warfarin), preoperative haematocrit, postoperative 
haematocrit, wound closure (barbed suture, monocryl) and postoperative 
thromboprophylaxis (clexane, aspirin, clopidogrel, novel anticoagulants, warfarin). 
The R2 values were inspected to determine if multicollinearity was a problem in the 
model, if the R2 value was >0.75 then the included values were rationalised. 
Significance was determined when p < 0.05. 
 
Results 
The mean blood loss was 965mls (SD 474). The mean blood loss when the femur was 
prepared first was 946mls (SD 500) and when the femur was prepared second was 
985mls (SD 450). There was a reduction in total blood loss for the femur first group 
(mean of 39mls). 
  
Table 1. Patient demographics 
 
The multiple regression model for the total volume of blood loss (including hidden 
blood loss) showed a significant relationship (p<0.0001). Gender (p<0.0001), Body 
Mass Index (BMI; p<0.0001), preoperative haematocrit (p<0.0001), postoperative 
haematocrit (p<0.0001) and age (p=0.004) were the only factors significantly 
associated with the total volume of blood loss. Whether the femur was prepared before 
or after the acetabulum did not significantly predict the total volume of blood loss 
(p=0.392). 
 
Table 2. Statistical outcomes 
 
Discussion 
Techniques to reduce blood loss during arthroplasty surgery continue to be evaluated. 
There is now a considerable body of level 1 evidence supporting the use of tranexamic 
acid in arthroplasty surgery. Sukeik et al [12] conducting a systematic review and meta-
analysis in 2011 which concluded that tranexamic acid significantly reduced intra-
operative blood loss and transfusion requirements after primary THR. While 
tranexamic acid has been shown to be effective, novel approaches such as the use of a 
bipolar sealer (a device which functions to shrink the collagen in the walls of the tissue 
vessels without causing charring and burning, as opposed to standard electrocautery) 
did not show significant reduction in the need for blood transfusions or significant 
reductions in overall blood loss [13]. We attempted to establish whether the order of 
surgical steps in standard THR could reduce total blood loss. 
Our two patient groups were well matched in gender, age, BMI and ASA. There 
was a small reduction in total blood loss with the femur first technique with a mean 
difference of 39 mls. This mean difference did not however, reach statistical 
significance (p=0.392). Gender, Body Mass Index and age were all shown to be 
statistically influential factors in blood loss for THR. Increased BMI was correlated 
with increased blood loss in this cohort. The evidence to date on the association of BMI 
and blood loss with some studies agreeing with our findings [14] and others finding no 
association [15]. BMI may be amenable to optimisation prior to surgery but although it 
is acknowledged that risks of outcomes such as revision and mortality are associated 
with BMI, it has yet to be demonstrated that interventions to modify BMI prior to THR 
also modify these risks. Gender and age have also been reported as significant factors 
which effect total blood loss as reported by Miao et al. in 2015 with their review of 
hidden blood loss in 322 patients [14] but are not amenable to preoperative 
optimisation. Our findings regarding haematocrit are in support of other literature, 
which recommends haematocrit optimisation prior to hip replacement surgery [8,16-
18].  
Interestingly, the mean total blood loss from THR is lower in our cohort of 100 
patients (965 mls) than the previous documented average total blood loss from Sehat et 
al. of 101 patients (1510 mls) [2]. Both groups of patients were operated on through the 
same tertiary elective orthopaedic centre with the first cohort being operated on in 
1999-2001 and our cohort 2014-2018. In over a decade in the same institution, mean 
total blood loss has decreased by over 500 mls. This difference is consistent with that 
observed by other authors on the introduction of tranexamic acid [19]. Continued 
research and development in this area may yet see further decreases in the mean total 
blood loss form THR and other major orthopaedic operations. 
The main limitation of this study is the number of patients recruited. We performed an 
a priori power calculation which predicts that a study of 4664 patients would be 
required to show statistical significance between the two techniques due to the small 
effect size (0.082) shown in the difference between these two patient groups.  
 
Conclusion 
Gender (p<0.0001), Body Mass Index (BMI; p<0.0001), preoperative haematocrit 
(p<0.0001), postoperative haematocrit (p<0.0001) and age (p=0.004) were factors 
significantly associated with the total volume of blood loss. Whether the femur was 
prepared before or after the acetabulum did not significantly predict the total volume of 
blood loss (p=0.392). 
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Table 1: Patient Demographics 
  
 
 
 
 
 
 
 
 
 Femur Prepared First Femur Prepared 
Second 
Mean total blood loss mls (SD) 946 (500) 985 (450) 
Gender (Male:Female) 23:27 23:27 
Mean BMI (SD) 29.3 (6.6) 30.8 (6.7) 
Median age (IQR) 72 (66,81) 68 (59,76) 
Median ASA grade (IQR) 2 (2,3) 2 (2,3) 
Mean preoperative 
haematocrit (SD) 
0.412 (0.041) 0.415 (0.042) 
Mean postoperative 
haematocrit (SD) 
0.337 (0.042) 0.340 (0.043) 
THR fixation 
(cemented:hybrid:uncemented) 
21:26:3 18:27:5 
Wound closure (barbed 
suture:monocryl) 
50:0 36:14 
Table 2. Statistical outcomes 
 
 t ratio p value Significant 
Femur first 0.860 0.392 No 
Gender 9.724 <0.0001 Yes 
BMI 6.472 <0.0001 Yes 
Age 2.939 0.004 Yes 
ASA grade 0.177 0.860 No 
Preoperative 
haematocrit 
29.839 <0.0001 Yes 
Postoperative 
haematocrit 
36.739 <0.0001 Yes 
THR fixation 0.958 0.341 No 
Preoperative 
anticoagulant 
0.630 0.530 No 
Wound closure 0.608 0.545 No 
Postoperative 
thromboprophylaxis 
1.619 0.109 No 
 
